Tildrakizumab
Tildrakizumab reduces the effects of a substance in the body that can cause inflammation. Tildrakizumab is used to treat moderate to severe&...
sirukumab
Plivensia (sirukumab) is a human anti-interleukin-6 monoclonal antibody in development for the treatment of rheumatoid arthritis.Sirukumab h...
mepolizumab
Mepolizumab is an anti-IL-5 IgG1 kappa monoclonal antibody indicated as an add-on maintenance treatment in patients aged six years and older...
secukinumab
Secukinumab (Cosentyx) is a human monoclonal antibody designed for the treatment of uveitis, rheumatoid arthritis, ankylosing spondylitis, a...
Benralizumab
Benralizumab is indicated as a maintenance treatment of patients 12 years or older with severe asthma and an eosinophilic phenotype. Th...
RESLIZUMAB
Reslizumab is used together with other medicines to help control severe asthma in adults. Reslizumab affects your immune system, r...
Canakinumab
Canakinumab is a monoclonal antibody that blocks certain proteins in the body that can affect inflammation and other immune responses. Canak...
Basiliximab
A recombinant chimeric (murine/human) monoclonal antibody (IgG1k) that functions as an immunosuppressive agent, specifically binding to and ...